3种抗生素治疗下呼吸道感染的药物经济学分析

Analysis by pharmaceutical-economic principle to comparing the three antibiotics in the treatment of lower respiratory tract infection

运用药物经济学原理,比较3种抗生素治疗下呼吸道感染的疗效和费用。方法回顾性调查我院2007年1月～2008年12月应用3种抗生素治疗中重度下呼吸道感染的96例临床病历,分析了其药物利用及成本消耗情况。结果疗效-成本分析表明,哌拉西林/他唑巴坦具有较好的疗效成本比。结论哌拉西林/他唑巴坦具有较好的疗效成本比。

OBJECTIVE By using pharmaceutical-economic principle to comparing the curative effect and cost of three antibiotics in the treatment of lower respiratory tract infection. METHODS Retrospective sample of 96 severe lower respiratory tract infection cases during the period of Jan. 2007 to Dec. 2008 was investigated and the administration of medicine and the cost-effectiveness were analyzed. RESULTS Cost-effectiveness analysis shows that piperacillin/tazobactam have better ratio of effectiveness to cost. CONCLUSION Piperacillin/tazobactam have better ratio of effectiveness to cost.